Post Hair Transplant Exosome Recovery Protocol | Ossome PRO EXO

Part of the PRO EXO Professional Series — clinical-grade exosome vials for hair transplant surgeons, dermatologists, and aesthetic clinics.

The 72 hours following a hair transplant are one of the most consequential windows in the entire patient journey. Graft survival, healing velocity, and long-term density outcomes are shaped in large part by what happens to the scalp microenvironment in the days and weeks after surgery.

Yet most post-transplant care protocols remain reactive — managing infection risk and patient expectations, rather than actively supporting the biological conditions grafts need to take and thrive.

The Ossome PRO EXO Series offers a different approach: a modular set of clinical-grade exosome vials designed to work with the scalp's own regenerative biology across each stage of the recovery window.

Why the post-transplant window is underserved

Hair transplant outcomes are measured months later — but they are largely determined in the first few weeks. The challenges clinics commonly face during this window include:

Inflammatory response

Surgical trauma triggers inflammation that can compromise graft take if not actively modulated.

Scalp barrier disruption

Incision sites leave the scalp vulnerable to transepidermal water loss and microbial challenge.

Shock loss in native follicles

Telogen effluvium affecting surrounding hair can erode patient confidence before results appear.

Microbial imbalance

Disrupted scalp flora post-procedure creates conditions for opportunistic colonisation and irritation.

What exosome therapy addresses in the recovery window

Exosomes are extracellular vesicles that carry proteins, growth factors, and signalling molecules between cells. When applied to post-surgical scalp tissue, they function as biological messengers — not introducing foreign material, but activating the scalp's own repair processes.

Key mechanisms relevant to post-transplant recovery

Modulation of the inflammatory cascade without suppressing the healing response
Acceleration of epithelial barrier repair at graft sites
Promotion of angiogenesis to restore blood supply to transplanted follicles
Support for hair cycle re-entry in shocked surrounding native follicles
Scalp microbiome stabilisation through antimicrobial peptides and signalling molecules

The PRO EXO modular recovery protocol

Rather than a single fixed product, the PRO EXO Series is applied in phases — each addressing the dominant biological challenge at that stage of recovery. Clinicians can adapt the combination to each patient's presentation and response.

Phase 1
Days 0–7

Inflammation control + barrier repair — KERAPAIR line

Prioritise the KERAPAIR vials in the immediate post-operative window. The focus is calming the acute inflammatory response, sealing exposed graft channels, and preventing transepidermal water loss from disrupted tissue.

Phase 2
Weeks 2–4

Microbiome stabilisation — AZOLEI line

As surface healing progresses, microbial balance becomes the dominant challenge. Introduce AZOLEI to address opportunistic colonisation, reduce scalp irritation, and create a stable microenvironment for grafts to consolidate.

Phase 3
Weeks 4–12

Cycle activation + density support — MINOX line

With the surgical site stabilised, shift focus to supporting anagen re-entry in grafted and surrounding follicles. The MINOX line targets the hair growth cycle to reduce shock loss and reinforce long-term density outcomes.

Why modular matters for post-transplant patients

No two post-transplant scalps present identically. A patient with an underlying microbiome imbalance needs a different primary intervention than one whose dominant challenge is barrier disruption or shock loss risk. A fixed-protocol product applies the same formulation regardless.

The PRO EXO modular system lets clinicians sequence and weight the intervention based on what each patient's scalp actually shows — adjusting emphasis between lines as the recovery progresses and the clinical picture changes.

Clinical evidence

A review published in Clinical and Translational Medicine documents the role of exosomes in wound healing, angiogenesis, and hair follicle activation — the three biological processes most critical to post-transplant outcomes (PMC9189765).

A 2024 study in the Journal of Cosmetic Dermatology demonstrated that exosome application via non-invasive delivery improved hair density and follicle activation in androgenetic alopecia patients, providing a clinical basis for their use in scalp recovery protocols.